Program
Thursday, April 16, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6:30 PM - 7:00 PM | Information | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7:00 PM - 8:00 PM | Keynote | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
8:15 PM - 9:15 PM | Information | Information | Information | Information | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
9:30 PM - 10:30 PM | Information | Information | Information | Information | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10:35 PM - 10:45 PM | Closing |
Wait – CFTR isn’t Just in the Lungs?!?
Drucy Borowitz
Senior Vice President of Community Partnerships, Cystic Fibrosis Foundation
Drucy Borowitz
Senior Vice President of Community Partnerships, Cystic Fibrosis Foundation
Be the Voice in CF Research
Jp Clancy
Senior Vice President of Clinical Research, Cystic Fibrosis Foundation
Jp Clancy
Senior Vice President of Clinical Research, Cystic Fibrosis Foundation
After Trikafta: The Future of Modulators and Potential Effects on Treating CF
Patrick Flume
Professor of Medicine and Pediatrics
Patrick Flume
Professor of Medicine and Pediatrics
The Three R’s of CFTR: Restore, Repair, Replace
CF 101: Decoding CFTR Genetics to Transform Treatment
Closing
James Lawlor
Adult with CF
CF 101: Decoding CFTR Genetics to Transform Treatment
Closing
James Lawlor
Adult with CF
Sexual and Reproductive Health in the Era of CFTR Modulators
Jennifer Taylor-Cousar, MD, MSCS, ATSF
Associate Professor of Adult and Pediatric Pulmonary Medicine, National Jewish Health
Jennifer Taylor-Cousar, MD, MSCS, ATSF
Associate Professor of Adult and Pediatric Pulmonary Medicine, National Jewish Health
Changing CF Care in the Era of Trikafta: Are We There Yet?
Dave Nichols
Professor of Pediatrics, Seattle Children’s Hospital at the University of Washington
Dave Nichols
Professor of Pediatrics, Seattle Children’s Hospital at the University of Washington
After Trikafta: The Future of Modulators and Potential Effects on Treating CF
George Retsch-Bogart, MD
Professor of Pediatrics
George Retsch-Bogart, MD
Professor of Pediatrics
Therapeutic Approaches for Rare and Nonsense Mutations
Peter Haggie, PhD
Associate Professor, Medicine at the University of California, San Francisco
Peter Haggie, PhD
Associate Professor, Medicine at the University of California, San Francisco
CF 101: Decoding CFTR Genetics to Transform Treatment
Elinor Langfelder-Schwind
Genetic Counselor, Regulatory Research Coordinator at Beth Israel Medical Center
Elinor Langfelder-Schwind
Genetic Counselor, Regulatory Research Coordinator at Beth Israel Medical Center